69ɫ��Ƭ

As part of an ongoing series in On the Risk, 69ɫ��Ƭ's Taylor Pickett, an actuary, and Catie Muccigrosso, an underwriter, examine the relationship between their professions and underscore the crucial role underwriters play in the development and implementation o...

Read More

Up to 70% of breast cancer patients prescribed chemotherapy after their surgeries might not need it. But how can clinicians make that decision, and insurers determine whether to cover the determining tests?  Read More

Adjudication of overseas claims may be challenging, but being aware of red flags and having an effective claims strategy and processing framework will help ensure the validity of claims and avoid fraudulent activity. 
Read More

More than a year after a pandemic transformed the world of work, how are group disability insurers responding?  At 69ɫ��Ƭ’s 27th annual Disability Claim Leaders Forum, representatives from major carriers shared intriguing insights. 

Read More

Curious about 69ɫ��Ƭ's medical insights?  Contact us to learn m...

Read More

For 69ɫ��Ƭ's Curt Zepeda, underinsurance is an existential challenge for the insurance industry, and yet the digital tools are available to the group insurance sector to provide more personalized offers and help close the protection gap. He calls on the industry to ba... Read More

In 2020, 69ɫ��Ƭ produced a five-part series of articles exploring life insurance fraud in the time of COVID-19 as a lead-up to the 69ɫ��Ƭ Fraud Conference.  Read More

It's the million-dollar question: how should insurers respond to an emerging class of gene therapeutics that promise to cure or ease debilitating genetic disorders, rare diseases and cancers but can cost upwards of $1 million per treatment. Learn highlights from...

Read More

For insurers, the current puzzle is how to develop cost-effective products for mental health disorders with sufficient flexibility to cover a range of risks and maintain positive customer experiences, says 69ɫ��Ƭ's Dipali Jawalkar, Executive D...

Read More

Curious about 69ɫ��Ƭ’s Global Genetics Survey results? 

Read More

Brain fog ... blurred vision ... loss of taste ... these are just a few of the lingering, and sometimes debilitating, symptoms reported by COVID-19 long-haulers. Read More

Aligning Critical Illness definitions with clinical diagnoses is not an easy task, and the speed of medical advances can lead to difficulties applying CI definitions at claims stage. 69ɫ��Ƭ's Marilda Kotze and Anne Casey explore some of the common challenges that this c...

Read More

Medicine never stands still; so neither can underwriting. For accurate, best-in-class risk calculation, the industry needs precise, flexible, and convenient solutions.

69ɫ��Ƭ has harnessed its global research and data science capabilities and partnered with clients ... Read More

Curious about 69ɫ��Ƭ's data science insights?  Contact us to le...

Read More

The novel coronavirus has forced many of us to confront our own vulnerability to loss and to think more seriously about planning for our family’s protection, according to 69ɫ��Ƭ's Dr. Dave Rengachary. He calls on the industry to consider how to make insurance products more... Read More

The global effort to develop mRNA-based vaccines for COVID-19 has greatly advanced mRNA technology and increased the speed of mRNA vaccine development, and it is likely that new mRNA vaccines for other diseases will soon emerge. Read More

Challenges have a way of driving change. 69ɫ��Ƭ's Naohiro Iwamoto looks back at the pandemic year of 2020 and surveys the many ways COVID-19 has accelerated change throughout the insurance industry and beyond.

Read More

Could anxiety and uncertainty fuelled by an ongoing pandemic lead to a mental health crisis? 69ɫ��Ƭ's Enrique Ruiz, Managing Director of Spain and Portugal, explores this question in

Read More

The global burden of gestational diabetes mellitus (GDM) is on the rise alongside increases in obesity and changing lifestyles. In ReFlections, 69ɫ��Ƭ's Dr. Reema Nathwani Jani explores the history, complications, management, and long-term outcomes of GDM on ma...

Read More

Underwriting pulmonary and thyroid nodules has always been a distinct challenge. In a two-part article for ReFlections, 69ɫ��Ƭ's Sandeepan Basu seeks to simplify the underwriting challenges associated with both types of nodules by identifying factors to ... Read More